Stay updated on Pembrolizumab for High Risk Oral Neoplasia Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.

Latest updates to the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded site revision tag v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check23 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check52 days agoChange DetectedThe site version was updated to Revision: v3.4.2 and an older government funding status notice was removed, with no changes to the study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedA site-wide notice about government funding lapse and NIH operations was added, and the page shows a version update from v3.4.0 to v3.4.1. These updates do not alter the trial details or data presented.SummaryDifference0.4%

- Check66 days agoChange DetectedUI changes include adding a glossary toggle, introducing result-status labels (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted) and a No FEAR Act Data notice, plus a Revision: v3.4.0; older labels such as Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check80 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; there are no changes to study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for High Risk Oral Neoplasia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.